Most. Nihat Farhana

COVID-19 PROTECTED through WHO APPROVAL of TWO NEW DRUGS WHO has approved two more drugs as recommended treatments for COVID-19, as the more infectious Omicron variant of the coronavirus triggers an unprecedented surge in cases around the world. British researchers have mentioned young and babies are more likely to be affected by Omicron variant compared to older ones but the situation is still under control. The drug baricitinib, that is additionally accustomed treat arthritis, is “strongly recommended” for patients with severe or crucial COVID-19, together with corticosteroids. The panel additionally gave a “conditional recommendation” for “sotrovimab”, associate in nursing experimental antibody treatment Omicron variant is increasing at an alarming rate. Due to this reason, China, Hong Kong, UK & USA are considered to maintain most probable initiatives to protect valuable citizen’s lives. An alarming number of cases of COVID-19 were reported to the WHO in last week – by far the most in a single week – driven by the Omicron variant, which is replaced delta variant. For coping with this variant, we all should be conscious, used the masks and tried to maintain social distance during social interactions.